Supporto immunitario

KPV

Fascia di prezzo: da 175,00 $ a 240,00 $

Per vial
$17.50
10 vials per pack
Suggested retail
$52.50
3× markup · per vial
Spedizione gratuita per ordini superiori a 2.000 $
  • Garanzia di consegna Rispedizione gratuita in caso di mancata consegna
  • Purezza ≥99% Produzione diretta dal produttore
  • Certificati di analisi indipendenti Visualizza i COA per questo prodotto →
  • Garanzia di credito negozio Invia qualsiasi risultato COA e ricevi un credito negozio

KPV — Lysine-Proline-Valine Anti-Inflammatory Tripeptide

KPV is a three-amino-acid peptide – Lysine-Proline-Valine – that forms the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). While the full alpha-MSH peptide is best known for pigmentation signaling, the KPV fragment retains most of alpha-MSH’s anti-inflammatory activity while losing its melanocortin-receptor agonism. That is why researchers use KPV on its own – it isolates the anti-inflammatory arm of alpha-MSH biology without the pigmentation or appetite effects.


Why the Tripeptide Form Matters

KPV is small enough to be absorbed intact through the PepT1 transporter in the intestinal epithelium, which is the reason oral-delivery studies exist for it (most peptides this short would simply be degraded). Once inside the cell, it is cited in literature as downregulating NF-kappaB signaling and suppressing pro-inflammatory cytokine release. It is one of the few peptides with a published profile covering injected, oral, and topical routes.

Percorso In parole povere, ecco cosa fa
PepT1 transporter (gut) Carries KPV intact through the intestinal wall – the reason oral studies exist
NF-kappaB signaling Downregulated; cited in most KPV anti-inflammatory literature
Mast cells and macrophages Reduced pro-inflammatory cytokine release in published in-vitro work

KPV vs BPC-157

These two show up together in a lot of gut-repair literature, so the distinction matters.

Peptide Via principale Most-studied application
KPV Anti-inflammatory (NF-kappaB suppression) Colitis models, skin inflammation, mast-cell regulation
BPC-157 Angiogenesis and tissue repair (VEGF, nitric-oxide) GI mucosa, tendon, ligament

Researchers pair them in some study designs (KPV + BPC-157 capsules appear in the published literature) because the mechanisms are non-overlapping – one suppresses inflammation, the other builds structural repair.


Applicazioni di ricerca

KPV is used in studies examining:

  • Colitis and intestinal-inflammation models (including the PepT1 oral-absorption pathway)
  • Mast-cell and macrophage anti-inflammatory signaling
  • Skin-inflammation models (transdermal and topical delivery)
  • NF-kappaB-mediated cytokine suppression
  • Comparative repair-peptide study designs (KPV + BPC-157)
  • Delivery-route comparisons (injected, oral, transdermal)

Specifiche tecniche

Formato Polvere liofilizzata
Purezza ≥99%
Alias Lysine-Proline-Valine, Lys-Pro-Val, alpha-MSH (11-13) fragment
Taglie disponibili 5 mg · 10 mg
Archiviazione 2-8 °C se non aperto; stabile per oltre 12 mesi
Utilizzo Solo a scopo di ricerca – non destinato all'uso umano

Ricostituzione

KPV arrives as a freeze-dried powder and is reconstituted with bacteriostatic water:

Totale in mg nella fiala ÷ ml di acqua aggiunta = mg per ml

Esempio: una fiala da 5 mg + 2 ml di acqua batteriostatica = 2,5 mg per ml. Una fiala da 10 mg + 2 ml = 5 mg per ml.

Una volta ricostituito, conservare a una temperatura compresa tra 2 e 8 °C e utilizzare entro 28-30 giorni.


Note sul protocollo

The following values are reference points extracted from published KPV research – not instructions. Because KPV has both injected and oral literature, published protocols vary by route.

  • Dose range reported in the literature: 250-500mcg per administration
  • Frequenza di somministrazione negli studi pubblicati: la somministrazione una volta al giorno è quella più comunemente riportata
  • Study durations reported: 4-8 weeks for inflammation and mucosal-repair endpoints

Common Questions About KPV Research

What does KPV do in research?

It is most commonly studied as an anti-inflammatory signaling peptide. In published in-vitro and animal work it downregulates NF-kappaB, reduces pro-inflammatory cytokine release from mast cells and macrophages, and is absorbed intact through the PepT1 gut transporter – which is why it appears in colitis and intestinal-inflammation models.

How is KPV different from BPC-157?

They act through different pathways. KPV is an anti-inflammatory tripeptide that suppresses NF-kappaB signaling. BPC-157 is a 15-amino-acid peptide most closely associated with angiogenesis and structural tissue repair. The two are sometimes paired in gut-repair research designs because the mechanisms do not overlap.

Can KPV be taken orally in research?

Yes – KPV is one of the few peptides with published oral-absorption data, because the PepT1 transporter carries the tripeptide across the intestinal wall intact. Injected and transdermal delivery are also represented in the literature. Route selection in a study depends on the endpoint being measured.

Is KPV FDA approved?

No. KPV is not approved by the FDA for any human use. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is KPV stored?

Le fiale non aperte vanno conservate a una temperatura compresa tra 2 e 8 °C e mantengono la loro stabilità per oltre 12 mesi. Una volta ricostituita con acqua batteriostatica, la soluzione va conservata a una temperatura compresa tra 2 e 8 °C e utilizzata entro 28-30 giorni.


Garanzia di purezza

Ogni lotto ha una purezza pari o superiore al 99%. Inviateci un certificato di analisi (COA) redatto da un ente indipendente e vi accrediteremo un buono acquisto indipendentemente dai risultati riportati.